Skip to content
Brand AI

Kyowa Kirin

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2022

    Cumberland Pharmaceuticals acquires U.S. rights to SANCUSO

    Cumberland Pharmaceuticals announced that it had entered into and closed an agreement to acquire SANCUSO from Kyowa Kirin, including U.S. rights and full commercial responsibility for the product. Kyowa Kirin retained international rights.

    Source